HOOKIPA PHARMA INC. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
HOOKIPA PHARMA INC. reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$15.43 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2025-05-15
- HOOKIPA PHARMA INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-03-31 was -$15.43M, a 207.26% decline year-over-year.
- HOOKIPA PHARMA INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2024-12-31 was -$24.95M.
- HOOKIPA PHARMA INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2024-09-30 was -$13.84M.
- HOOKIPA PHARMA INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2024-06-30 was -$19.09M.
- HOOKIPA PHARMA INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2024 was -$43.50M.
- HOOKIPA PHARMA INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2023 was -$81.58M.
- HOOKIPA PHARMA INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2022 was -$64.92M.
- HOOKIPA PHARMA INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2021 was -$75.67M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2025-03-31 | -$15.43M 10-Q · filed 2025-05-15 | -$40.38M derived: sum of 2 quarters · filed 2025-05-15 | -$54.22M derived: sum of 3 quarters · filed 2025-05-15 | -$73.31M derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-12-31 | -$24.95M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$38.79M derived: sum of 2 quarters · filed 2025-02-28 | -$57.89M derived: sum of 3 quarters · filed 2025-02-28 | -$43.50M 10-K · filed 2025-02-28 |
| 2024-09-30 | -$13.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$32.94M derived: sum of 2 quarters · filed 2024-11-14 | -$18.55M 10-Q · filed 2024-11-14 | -$43.37M derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-06-30 | -$19.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$4.71M 10-Q · filed 2024-08-08 | -$29.53M derived: sum of 3 quarters · filed 2025-05-15 | -$48.60M derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-03-31 | $14.38M 10-Q · filed 2025-05-15 | -$10.44M derived: sum of 2 quarters · filed 2025-05-15 | -$29.50M derived: sum of 3 quarters · filed 2025-05-15 | -$47.52M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | -$24.82M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$43.88M derived: sum of 2 quarters · filed 2025-02-28 | -$61.90M derived: sum of 3 quarters · filed 2025-02-28 | -$81.58M 10-K · filed 2025-02-28 |
| 2023-09-30 | -$19.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$37.08M derived: sum of 2 quarters · filed 2024-11-14 | -$56.76M 10-Q · filed 2024-11-14 | -$69.07M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | -$18.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$37.70M 10-Q · filed 2024-08-08 | -$50.01M derived: sum of 3 quarters · filed 2025-02-28 | -$68.29M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | -$19.68M 10-Q · filed 2024-05-09 | -$31.99M derived: sum of 2 quarters · filed 2025-02-28 | -$50.27M derived: sum of 3 quarters · filed 2025-02-28 | -$66.63M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | -$12.31M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$30.59M derived: sum of 2 quarters · filed 2025-02-28 | -$46.95M derived: sum of 3 quarters · filed 2025-02-28 | -$64.92M 10-K · filed 2025-02-28 |
| 2022-09-30 | -$18.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$34.64M derived: sum of 2 quarters · filed 2023-11-09 | -$52.60M 10-Q · filed 2023-11-09 | -$73.84M derived: sum of 4 quarters · filed 2024-03-22 |
| 2022-06-30 | -$16.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$34.32M 10-Q · filed 2023-08-10 | -$55.56M derived: sum of 3 quarters · filed 2024-03-22 | -$75.60M derived: sum of 4 quarters · filed 2024-03-22 |
| 2022-03-31 | -$17.97M 10-Q · filed 2023-05-11 | -$39.20M derived: sum of 2 quarters · filed 2024-03-22 | -$59.24M derived: sum of 3 quarters · filed 2024-03-22 | -$76.39M derived: sum of 4 quarters · filed 2024-03-22 |
| 2021-12-31 | -$21.23M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | -$41.27M derived: sum of 2 quarters · filed 2024-03-22 | -$58.43M derived: sum of 3 quarters · filed 2024-03-22 | -$75.67M 10-K · filed 2024-03-22 |
| 2021-09-30 | -$20.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$37.19M derived: sum of 2 quarters · filed 2022-11-14 | -$54.43M 10-Q · filed 2022-11-14 | -$66.90M derived: sum of 4 quarters · filed 2023-03-15 |
| 2021-06-30 | -$17.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$34.39M 10-Q · filed 2022-08-11 | -$46.87M derived: sum of 3 quarters · filed 2023-03-15 | -$60.45M derived: sum of 4 quarters · filed 2023-03-15 |
| 2021-03-31 | -$17.24M 10-Q · filed 2022-05-16 | -$29.71M derived: sum of 2 quarters · filed 2023-03-15 | -$43.30M derived: sum of 3 quarters · filed 2023-03-15 | -$50.39M derived: sum of 4 quarters · filed 2023-03-15 |
| 2020-12-31 | -$12.47M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | -$26.06M derived: sum of 2 quarters · filed 2023-03-15 | -$33.16M derived: sum of 3 quarters · filed 2023-03-15 | -$44.08M 10-K · filed 2023-03-15 |
| 2020-09-30 | -$13.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$20.68M derived: sum of 2 quarters · filed 2021-11-10 | -$31.61M 10-Q · filed 2021-11-10 | -$41.85M derived: sum of 4 quarters · filed 2022-03-24 |
| 2020-06-30 | -$7.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$18.02M 10-Q · filed 2021-08-12 | -$28.26M derived: sum of 3 quarters · filed 2022-03-24 | -$39.65M derived: sum of 4 quarters · filed 2022-03-24 |
| 2020-03-31 | -$10.93M 10-Q · filed 2021-05-12 | -$21.17M derived: sum of 2 quarters · filed 2022-03-24 | -$32.55M derived: sum of 3 quarters · filed 2022-03-24 | -$44.63M derived: sum of 4 quarters · filed 2022-03-24 |
| 2019-12-31 | -$10.24M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | -$21.63M derived: sum of 2 quarters · filed 2022-03-24 | -$33.71M derived: sum of 3 quarters · filed 2022-03-24 | -$43.04M 10-K · filed 2022-03-24 |
| 2019-09-30 | -$11.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$23.46M derived: sum of 2 quarters · filed 2020-11-12 | -$32.79M 10-Q · filed 2020-11-12 | -$34.69M derived: sum of 4 quarters · filed 2021-03-18 |
| 2019-06-30 | -$12.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | -$21.41M 10-Q · filed 2020-08-13 | -$23.30M derived: sum of 3 quarters · filed 2021-03-18 | -$27.25M derived: sum of 4 quarters · filed 2021-03-18 |
| 2019-03-31 | -$9.33M 10-Q · filed 2020-05-14 | -$11.22M derived: sum of 2 quarters · filed 2021-03-18 | -$15.17M derived: sum of 3 quarters · filed 2021-03-18 | -$20.99M derived: sum of 4 quarters · filed 2021-03-18 |
| 2018-12-31 | -$1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | -$5.84M derived: sum of 2 quarters · filed 2021-03-18 | -$11.66M derived: sum of 3 quarters · filed 2021-03-18 | -$16.24M 10-K · filed 2021-03-18 |
| 2018-09-30 | -$3.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$9.77M derived: sum of 2 quarters · filed 2019-11-12 | -$14.35M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | -$5.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | -$10.39M 10-Q · filed 2019-08-12 | ||
| 2018-03-31 | -$4.57M 10-Q · filed 2019-05-20 | |||
| 2017-12-31 | -$12.72M 10-K · filed 2020-03-19 |